AGP Picks
View all

Medical Industry Today
Provided by AGP

Medical Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 15, 2026

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC
May 15, 2026

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

Indeterminate GlobeNewswire
BioCardia Reports First Quarter 2026 Business Highlights and Financial Results
May 15, 2026

BioCardia Reports First Quarter 2026 Business Highlights and Financial Results

Indeterminate GlobeNewswire
LifeMD to Participate in Upcoming Investor Conferences
May 15, 2026

LifeMD to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)
May 15, 2026

Belite Bio Announces Oral Presentation at the 27th Fundus Disease Forum and International Retinal Symposium (Retina China 2026)

Indeterminate GlobeNewswire
GT Biopharma Reports First Quarter 2026 Financial Results
May 15, 2026

GT Biopharma Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Lifeward Reports First Quarter 2026 Financial Results
May 15, 2026

Lifeward Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
May 15, 2026

Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
May 15, 2026

BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

Indeterminate GlobeNewswire
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
May 15, 2026

MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation

Indeterminate GlobeNewswire
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
May 15, 2026

Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology

Indeterminate GlobeNewswire
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
May 15, 2026

Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Profusa Announces Listing Transfer to The Nasdaq Capital Market
May 15, 2026

Profusa Announces Listing Transfer to The Nasdaq Capital Market

Indeterminate GlobeNewswire
Intercontinental ICU Air Ambulance Transport Highlights Growing Need for Continuous In-Flight Medical Care
May 15, 2026

Intercontinental ICU Air Ambulance Transport Highlights Growing Need for Continuous In-Flight Medical Care

Indeterminate GlobeNewswire
Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care
May 15, 2026

Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care

Indeterminate GlobeNewswire
Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder
May 15, 2026

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Indeterminate GlobeNewswire
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
May 15, 2026

Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC

Indeterminate GlobeNewswire
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026

Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses
May 15, 2026

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

Indeterminate GlobeNewswire
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
May 15, 2026

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.